This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kumakura, S.-i. Articles by Tsutsui, T. Search for Related Content PubMed PubMed Citation Articles by Kumakura, S.-i. Articles by Tsutsui, T.

Reversible Conversion of Immortal Human Cells from Telomerase-Positive to Telomerase-Negative Cells

¹ Department of Pharmacology, Nippon Dental University, School of Dentistry at Tokyo, Tokyo, Japan and ² Laboratory of Biosystems and Cancer, National Cancer Institute, NIH, Bethesda, Maryland

Requests for reprints: J. Carl Barrett, Center for Cancer Research, National Cancer Institute, Building 31, Room 3A11, 31 Center Drive, MSC-2440, Bethesda, MD 20892-2240. Phone: 301-496-4345; Fax: 301-496-0775; E-mail: barrett{at}mail.nih.gov.

Immortal cell lines and tumors maintain their telomeres via the telomerase pathway or via a telomerase-independent pathway, referred to as alternative lengthening of telomeres (ALT). Here, we show the reversible conversion of the human papillomavirus type 16 E6-induced immortal human fibroblasts E6 Cl 6 from telomerase-positive (Tel⁺) to telomerase-negative (Tel^–) cells. Tel⁺ cells converted spontaneously to Tel^– cells that reverted to Tel⁺ cells following treatment with trichostatin A (TSA) and/or 5-aza-2'-deoxycytidine (5-AZC), which induced the reversion from complete to partial methylation of the CpG islands of the human telomerase reverse transcriptase (hTERT) promoter in Tel^– E6 Cl 6 cells. Tel^– E6 Cl 6 cells lacked the phenotypes characteristic of ALT cell lines such as very long and heterogenous telomeres and ALT-associated promyelocytic leukemia nuclear bodies (APB) but grew for >240 population doublings (PD) after they became telomerase negative. The ratios of histone H3 (H3) lysine (K) 9 methylation to each of H3-K4 methylation, H3-K9 acetylation, and H3-K14 acetylation of the chromatin containing the hTERT promoter in Tel^– E6 Cl 6 cells and ALT cell lines were greater than those in Tel⁺ cells and decreased following treatment with TSA and/or 5-AZC, inversely corresponding to telomerase activity. Our findings suggest the possibility that human tumors may be able to reversibly interconvert their telomere maintenance phenotypes by chromatin structure-mediated regulation of hTERT expression.

Key Words: immortal human cells • telomerase • alternative lengthening of telomeres • DNA methylation • chromatin structure

This article has been cited by other articles:

				C. Liu, X. Fang, Z. Ge, M. Jalink, S. Kyo, M. Bjorkholm, A. Gruber, J. Sjoberg, and D. Xu The Telomerase Reverse Transcriptase (hTERT) Gene Is a Direct Target of the Histone Methyltransferase SMYD3 Cancer Res., March 15, 2007; 67(6): 2626 - 2631. [Abstract] [Full Text] [PDF]

				S. Renaud, D. Loukinov, Z. Abdullaev, I. Guilleret, F. T. Bosman, V. Lobanenkov, and J. Benhattar Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene Nucleic Acids Res., February 28, 2007; 35(4): 1245 - 1256. [Abstract] [Full Text] [PDF]

				A. Brachner, S. Sasgary, C. Pirker, C. Rodgarkia, M. Mikula, W. Mikulits, H. Bergmeister, U. Setinek, M. Wieser, S.-F. Chin, et al. Telomerase- and Alternative Telomere Lengthening-Independent Telomere Stabilization in a Metastasis-Derived Human Non-Small Cell Lung Cancer Cell Line: Effect of Ectopic hTERT. Cancer Res., April 1, 2006; 66(7): 3584 - 3592. [Abstract] [Full Text] [PDF]

				A. Muntoni and R. R. Reddel The first molecular details of ALT in human tumor cells Hum. Mol. Genet., October 15, 2005; 14(suppl_2): R191 - R196. [Abstract] [Full Text] [PDF]

				S. P. Atkinson, S. F. Hoare, R. M. Glasspool, and W. N. Keith Lack of Telomerase Gene Expression in Alternative Lengthening of Telomere Cells Is Associated with Chromatin Remodeling of the hTR and hTERT Gene Promoters Cancer Res., September 1, 2005; 65(17): 7585 - 7590. [Abstract] [Full Text] [PDF]